Live news related to SANOFI stock (FR0000120578): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
Sanofi announced on Monday the appointment of Paulo Fontoura as Executive Vice President in charge of Global Pharma R&D, succeeding Houman Ashrafian w…
Sanofi and HEC Paris announced on Friday the launch of a scholarship program aimed at supporting ten students of the school's MBA program each year. T…
On Friday, Sanofi received regulatory approval from the Japanese Ministry of Health for the subcutaneous injection formulation of its Sarclisa (isatux…
The pharmaceutical company marks a strong rebound in mid-morning trading, following a significant drop the previous day. The stock is among the leader…
This afternoon, the pharmaceutical company weighs on the CAC 40 in a Parisian market itself in decline. The stock sinks below its short-term moving av…
The FDA grants accelerated approval to Tzield (teplizumab-mzwv) to slow down the degradation of endogenous insulin production in children aged 8 to 17…
The pharmaceutical company's stock falls during the session after the announcement this morning of the termination of a Phase 3 clinical study. The st…
Sanofi announced on Wednesday the discontinuation of its Phase 3 MOBILIZE study on riliprubart, a drug candidate for patients with refractory chronic …
The European Commission approved on Monday the subcutaneous formulation of Sarclisa (isatuximab), a treatment for multiple myeloma by Sanofi. This app…
Sanofi and Trackmania are launching a time-limited event partnership on Friday to educate gamers about daily diabetes management. The initiative is pa…
